Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IB Study of Biomarker Modulation by Celecoxib vs. Placebo in Women With Newly-Diagnosed Breast Cancer

NCT00328432 is registered in ClinicalTrials.gov with University of Kansas as lead sponsor.

NCT NCT00328432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00328432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IB Study of Biomarker Modulation by Celecoxib vs. Placebo in Women With Newly-Diagnosed Breast Cancer
Lead sponsor
University of Kansas
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2003
Completion date
December 31, 2005
Enrollment
100
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer